The successful treatment of disinhibition due to a possible case of non-human immunodeficiency virus neurosyphilis: a proposed pathophysiological explanation of the symptoms and treatment.
Spiegel
David R
DR
Department of Psychiatry and Behavioral Sciences, Eastern Virginia Medical School, Norfolk, VA 23507, USA. spiegedr@evms.edu
Qureshi
Nabeel
N
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000068180:Aripiprazole; D002220:Carbamazepine / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006801:Humans; D007266:Inhibition, Psychological; D008297:Male; D008875:Middle Aged; D009494:Neurosyphilis / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000503:physiopathology; D010879:Piperazines / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D002220:Carbamazepine; D000068180:Aripiprazole